A novel anti-p21Ras scFv antibody reacting specifically with human tumour cell lines and primary tumour tissues-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A novel anti-p21Ras scFv antibody reacting specifically with human tumour cell lines and primary tumour tissues

Published:2016-02-20 Issue:1 Volume:16 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Yang Ju-Lun,Liu Du-Xian,Zhen Shi-Jian,Zhou Yun-Gang,Zhang Dai-Jun,Yang Li-Ying,Chen Hao-Bing,Feng Qiang

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s12885-016-2168-6.pdf

Reference43 articles.

1. Lener M, Horn IR, Cardinale A, Messina S, Nielsen UB, Rybak SM, Hoogenboom HR, Cattaneo A, Biocca S. Diverting a protein from its cellular location by intracellular antibodies. The case of p21Ras. Eur J Biochem. 2000;267(4):1196–205.

2. Adjei AA. Blocking oncogenic Ras signaling for cancer therapy. J Natl Cancer Inst. 2001;93(14):1062–74.

3. Xin C, Ye S, Ming Y, Shenghua Z, Qingfang M, Hongxing G, Xu S, Yuanfu X, Yuan Z, Dongmei F, et al. Efficient inhibition of B-cell lymphoma xenografts with a novel recombinant fusion protein: anti-CD20Fab-LDM. Gene Ther. 2010;17(10):1234–43.

4. Sheng W, Shang Y, Miao Q, Li Y, Zhen Y. Antitumor efficacy of the scFv-based fusion protein and its enediyne-energized analogue directed against epidermal growth factor receptor. Anticancer Drugs. 2012;23(4):406–16.

5. Miao QF, Liu XY, Shang BY, Ouyang ZG, Zhen YS. An enediyne-energized single-domain antibody-containing fusion protein shows potent antitumor activity. Anticancer Drugs. 2007;18(2):127–37.

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RGD-p21Ras-scFv expressed prokaryotically on a pilot scale inhibits ras-driven colorectal cancer growth by blocking p21Ras-GTP;BMC Cancer;2024-01-12

2. Targeting small GTPases: emerging grasps on previously untamable targets, pioneered by KRAS;Signal Transduction and Targeted Therapy;2023-05-23

3. Single-Chain Fragment Variable: Recent Progress in Cancer Diagnosis and Therapy;Cancers;2022-08-30

4. BR2 cell penetrating peptide effectively delivers anti-p21Ras scFv to tumor cells with ganglioside expression for therapy of ras-driven tumor;PLOS ONE;2022-06-01

5. A method of delivering an anti-p21Ras single-chain antibody fragment to tumor sites in vivo;Journal of Drug Delivery Science and Technology;2022-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3